• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by BIO-key International Inc.

    2/14/24 3:30:35 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SC 13G 1 armistice-bkyi123123.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*



    BIO KEY INTERNATIONAL INC

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    09060C507

    (CUSIP Number)

     

     

    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    x Rule 13d-1(b)

    o Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No.  09060C507
     SCHEDULE 13G
    Page 2 of 8 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Armistice Capital, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    121,494
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    121,494
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    121,494
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99%
    12
    TYPE OF REPORTING PERSON
     
    IA, OO

     


     

    CUSIP No.  09060C507
     SCHEDULE 13G
    Page 3 of 8 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Steven Boyd
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States of America
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    121,494
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    121,494
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    121,494
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99%
    12
    TYPE OF REPORTING PERSON
     
    IN, HC

     


     

     

    CUSIP No. 09060C507
     SCHEDULE 13G
    Page 4 of 8 Pages

     

    Item 1.(a) Name of Issuer

    BIO KEY INTERNATIONAL INC

    Item 1.(b) Address of Issuer’s Principal Executive Offices

    101 Crawfords Corner Road, Suite 4116

    Holmdel, NJ 07733

    Item 2.(a) Names of Person Filing:

    Armistice Capital, LLC

    Steven Boyd

    Collectively, the "Reporting Persons"

      

    Item 2.(b) Address of Principal Business Office:

     

    Armistice Capital, LLC

    510 Madison Avenue, 7th Floor

    New York, New York 10022

    United States of America

     

    Steven Boyd

    c/o Armistice Capital, LLC

    510 Madison Avenue, 7th Floor

    New York, New York 10022

    United States of America

      

    Item 2.(c) Citizenship:

     

    Armistice Capital, LLC - Delaware

    Steven Boyd - United States of America

      

    Item 2.(d) Title of Class of Securities

     

    Common Stock, par value $0.0001 per share (“Shares”)

     

    Item 2.(e) CUSIP No.:

    09060C507

     

    CUSIP No.  09060C507
     SCHEDULE 13G
    Page 5 of 8 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     

    CUSIP No. 09060C507
     SCHEDULE 13G
    Page 6 of 8 Pages

     

     

    Item 4. Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a) Amount beneficially owned as of December 31, 2023:

    Armistice Capital, LLC - 121,494

    Steven Boyd - 121,494  

    (b) Percent of Class as of December 31, 2023:

    Armistice Capital, LLC - 9.99%

    Steven Boyd - 9.99% 

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote

    Armistice Capital, LLC - 0

    Steven Boyd - 0 

    (ii) Shared power to vote or to direct the vote

    Armistice Capital, LLC - 121,494

    Steven Boyd - 121,494 

    (iii) Sole power to dispose or to direct the disposition of

    Armistice Capital, LLC - 0

    Steven Boyd - 0 

    (iv) Shared power to dispose or to direct the disposition of

    Armistice Capital, LLC - 121,494

    Steven Boyd - 121,494

    The percentage of Shares reported to be beneficially owned by the Reporting Persons are based on information from the Issuer.

    Armistice Capital, LLC (“Armistice Capital”) is the investment manager of Armistice Capital Master Fund Ltd. (the "Master Fund"), the direct holder of the Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund. Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund. The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.

     

    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

    The Master Fund, a Cayman Islands exempted company that is an investment advisory client of Armistice Capital, has the right to receive dividends from, or the proceeds from the sale of, the reported securities.

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not Applicable.

    Item 8. Identification and Classification of Members of the Group

    Not Applicable.

    Item 9. Notice of Dissolution of Group 

    Not Applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
    CUSIP No. 09060C507
     SCHEDULE 13G
    Page 7 of 8 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2024

     

     

     

     

    Armistice Capital, LLC

           
      By:  /s/ Steven Boyd
       

    Steven Boyd

    Managing Member

           

           
      By:  /s/ Steven Boyd
       

    Steven Boyd

           

     

     
    CUSIP No. 09060C507
     SCHEDULE 13G
    Page 8 of 8 Pages

     

    Exhibit I

     

    JOINT FILING STATEMENT

     

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: February 14, 2024

     

     

    Armistice Capital, LLC

           
      By:  /s/ Steven Boyd
       

    Steven Boyd

    Managing Member

           
     

     
      By:  /s/ Steven Boyd
       

    Steven Boyd

           
    Get the next $BKYI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Biometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed. June 4 at 11am ET

      HOLMDEL, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless, Identity-Bound Biometric (IBB) authentication solutions today announces its participation at the Aegis Capital Corp. 2025 Virtual Conference on Thursday, May 22nd and the Maxim Virtual Tech Conference on Wednesday, June 4th – webcast access details provided below. Aegis Capital Virtual Conference 2025BIO-key PresentationDate/Time: Thursday, May 22, 2025, 11:30 – 11:55 a.m. ETWebcast Link: https://us02web.zoom.us/meeting/register/AfmnLxICTqmjEvoSG9-MMQ#/reg

      5/20/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East

      WALL, N.J. and RIYADH, Saudi Arabia, May 19, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, is pleased to announce a strategic partnership with Cloud Distribution Co., a prominent Value-Added Distributor (VAD) headquartered in Saudi Arabia, with operations across the Middle East. Cloud Distribution joins BIO-key's Channel Alliance Partner (CAP) program to deliver BIO-key's full suite of IAM and biometric authentication solutions to enterprises and public institutions in Saudi Arabia, the UAE, and across the region. This partnership strengthens BIO-key's local capabilities wh

      5/19/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    SEC Filings

    See more
    • BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:46:01 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by BIO-key International Inc.

      10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:31:41 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B3 filed by BIO-key International Inc.

      424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/12/25 4:31:59 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Depasquale Michael W bought $3,600 worth of shares (20,000 units at $0.18), increasing direct ownership by 7% to 306,827 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 10:12:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 8:35:57 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $6,505 worth of shares (39,671 units at $0.16), increasing direct ownership by 12% to 368,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      11/28/23 1:35:31 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bio-key upgraded by Maxim Group with a new price target

      Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

      3/26/21 7:52:25 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      11/14/24 5:05:04 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by BIO-key International Inc.

      SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/14/24 3:30:35 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/13/24 8:04:15 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    See more
    • BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

      DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

      12/11/23 7:59:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

      WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key

      6/2/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

      WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces

      1/3/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Williams Cameron E. was granted 3,897 shares, increasing direct ownership by 33% to 15,684 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:54:08 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Alia Emmanuel was granted 3,897 shares, increasing direct ownership by 31% to 16,323 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:49:05 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Michel Robert J was granted 3,897 shares, increasing direct ownership by 29% to 17,303 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:43:34 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Financials

    Live finance-specific insights

    See more
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET

      HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call DetailsDate / Time: Friday, May 16th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 monthsAudio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 65

      5/9/25 11:00:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET

      HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta

      3/27/25 7:58:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology